Meditative neurofeedback for treating depression
Meditative Neurofeedback for Depression
This study is testing whether a new 10-session meditation program using neurofeedback can help people with major depression feel better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 27 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of California, San Diego Academic / other |
| Locations | 1 site (La Jolla, California) |
| Trial ID | NCT06675240 on ClinicalTrials.gov |
What this trial studies
This open-label single-arm study aims to evaluate the effectiveness of a 10-session meditative neurofeedback intervention in alleviating symptoms of major depressive disorder. Participants will engage in neurofeedback sessions designed to enhance mindfulness and reduce rumination, with the goal of improving overall mood. The study will measure changes in depressive symptoms using standardized assessments, focusing on both primary and secondary outcomes related to mental health.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals experiencing moderate depression as indicated by PHQ9 symptom ratings.
Not a fit: Patients with active substance abuse, psychotic disorders, bipolar disorder, or those displaying acutely suicidal behaviors may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could provide a novel, non-pharmacological treatment option for individuals suffering from depression.
How similar studies have performed: While the approach of using meditative neurofeedback is relatively novel, similar studies have shown promising results in improving mental health outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * moderate depression per PHQ9 symptom ratings Exclusion Criteria: * active substance abuse/dependence * psychotic disorders * bipolar disorder * displaying acutely suicidal behaviors
Where this trial is running
La Jolla, California
- University of California San Diego — La Jolla, California, United States (Recruiting)
Study contacts
- Study coordinator: Jyoti Mishra, PhD
- Email: braine@ucsd.edu
- Phone: 619-940-4230
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.